<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2121-2-18.anc" start="23716" end="23720" sStart="-1" offset="0" sid="null" wn="2" wnkey="work%1:06:00::" text="Future &lt;b&gt;work&lt;/b&gt; will determine the relative contributions of these two classes of receptors in the biological effects of III1-C." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-2-18.anc" start="25724" end="25728" sStart="null" offset="32" sid="r7.1.use.v.0311" wn="1" wnkey="use%2:34:01::" text="The purified glycosaminoglycans used in this study were a generous gift of Dr. Nancy Schwartz (Univ." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-2-18.anc" start="35078" end="35089" sStart="null" offset="0" sid="null" wn="2" wnkey="transfer%2:40:01::" text="Samples were separated on 4-20% gradient Novex gels, &lt;b&gt;transferred&lt;/b&gt; to Immobilon P membranes, blocked with 5% nonfat dry milk in TBS-Tween, then probed with anti-phospho-p44/42 MAPK antibody according to the manufacturer's recommendations." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-2-18.anc" start="19239" end="19247" sStart="null" offset="78" sid="null" wn="3" wnkey="suggest%2:32:02::" text="Moreover, affinity chromatography with 35SO 4 -labeled cells suggests that HSPGs with core protein sizes of 46 kDa and 70 kDa serve as III1-C receptors." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-2-18.anc" start="19239" end="19247" sStart="null" offset="78" sid="null" wn="3" wnkey="suggest%2:32:02::" text="Moreover, affinity chromatography with 35SO 4 -labeled cells suggests that HSPGs with core protein sizes of 46 kDa and 70 kDa serve as III1-C receptors." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-2-18.anc" start="19239" end="19247" sStart="null" offset="78" sid="null" wn="3" wnkey="suggest%2:32:02::" text="Moreover, affinity chromatography with 35SO 4 -labeled cells suggests that HSPGs with core protein sizes of 46 kDa and 70 kDa serve as III1-C receptors." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-2-18.anc" start="19239" end="19247" sStart="null" offset="78" sid="null" wn="3" wnkey="suggest%2:32:02::" text="Moreover, affinity chromatography with 35SO 4 -labeled cells suggests that HSPGs with core protein sizes of 46 kDa and 70 kDa serve as III1-C receptors." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2121-2-18.anc" start="6622" end="6627" sStart="null" offset="0" sid="null" wn="5" wnkey="show%2:36:00::" text="As &lt;b&gt;shown&lt;/b&gt; in Figure 2, cells attach well to fibronectin and to III1-C, but not to III 11-C coated on a dish." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2121-2-18.anc" start="6622" end="6627" sStart="null" offset="0" sid="null" wn="5" wnkey="show%2:36:00::" text="As &lt;b&gt;shown&lt;/b&gt; in Figure 2, cells attach well to fibronectin and to III1-C, but not to III 11-C coated on a dish." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-2-18.anc" start="17890" end="17895" sStart="null" offset="115" sid="r7.serve.v.0092" wn="1" wnkey="serve%2:42:03::" text="The inhibition of 46 kDa and 70 kDa binding to III1-C by heparin suggests that these HSPGs may serve as receptors for III1-C in cell adhesion and ERK1/2 signaling." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-2-18.anc" start="24255" end="24260" sStart="null" offset="129" sid="r7.serve.v.0630" wn="1" wnkey="serve%2:42:03::" text="Results from various independent types of experiments indicate that the first type III repeat of fibronectin can serve as a cell binding domain and that both integrins and cell surface HSPGs function as receptors for this type III repeat." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-2-18.anc" start="25989" end="25994" sStart="null" offset="163" sid="r7.serve.v.0326" wn="1" wnkey="serve%2:42:03::" text="The glycosaminoglycans were produced under a contract from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH) and serve as reference standards." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-2-18.anc" start="17890" end="17895" sStart="null" offset="115" sid="r7.serve.v.0092" wn="1" wnkey="serve%2:42:03::" text="The inhibition of 46 kDa and 70 kDa binding to III1-C by heparin suggests that these HSPGs may serve as receptors for III1-C in cell adhesion and ERK1/2 signaling." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-2-18.anc" start="15653" end="15658" sStart="null" offset="103" sid="r7.serve.v.0712" wn="1" wnkey="serve%2:42:03::" text="This result is consistent with the idea that HSPGs but not chondroitin sulfate proteoglycans serve as signaling receptors for III1-C." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-2-18.anc" start="17890" end="17895" sStart="null" offset="115" sid="r7.serve.v.0092" wn="1" wnkey="serve%2:42:03::" text="The inhibition of 46 kDa and 70 kDa binding to III1-C by heparin suggests that these HSPGs may serve as receptors for III1-C in cell adhesion and ERK1/2 signaling." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-2-18.anc" start="17890" end="17895" sStart="null" offset="115" sid="r7.serve.v.0092" wn="1" wnkey="serve%2:42:03::" text="The inhibition of 46 kDa and 70 kDa binding to III1-C by heparin suggests that these HSPGs may serve as receptors for III1-C in cell adhesion and ERK1/2 signaling." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-2-18.anc" start="30149" end="30155" sStart="null" offset="225" sid="r8.number.n.0537" wn="1" wnkey="number%1:07:00::" text="To quantitate the amount of spreading, each image was analyzed with the NIH Image 1.61 application to determine the total amount of area covered by cells and this number was divided by the total number of cells in the image to give an average area per cell (in pixels 2/cell)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-2-18.anc" start="3838" end="3844" sStart="null" offset="256" sid="r9.normal.j.0946" wn="2" wnkey="normal%3:00:02::" text="III1-C is a recombinant fibronectin fragment that encompasses most of the first type III repeat, but is missing the A and B ?-strands of the repeat [ 2 ] . We had previously found that III1-C inhibited the growth of normal diploid smooth muscle cells (SMCs) in culture [ 4 ] . During these experiments we noticed that the presence of III1-C in the culture medium affected the morphology of cells at early times after plating." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2121-2-18.anc" start="10615" end="10620" sStart="null" offset="0" sid="null" wn="9" wnkey="know%2:31:11::" text="The 120 kDa and 140 kDa bands likely represent the ?1 and ?5 subunits (as above), while the 150 kDa band may represent either the ?2 or ?3 integrin subunits, which are &lt;b&gt;known&lt;/b&gt; to be expressed by VSMCs [ 26 ] . Affinity chromatography on the control III 11-C column yielded no radioiodinated proteins that were eluted from the column (Fig." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2121-2-18.anc" start="10615" end="10620" sStart="null" offset="0" sid="null" wn="9" wnkey="know%2:31:11::" text="The 120 kDa and 140 kDa bands likely represent the ?1 and ?5 subunits (as above), while the 150 kDa band may represent either the ?2 or ?3 integrin subunits, which are &lt;b&gt;known&lt;/b&gt; to be expressed by VSMCs [ 26 ] . Affinity chromatography on the control III 11-C column yielded no radioiodinated proteins that were eluted from the column (Fig." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-2-18.anc" start="29916" end="29922" sStart="null" offset="0" sid="null" wn="3" wnkey="image%1:06:00::" text="Cells were destained with water, air-dried, then photographed with a Leica DM IRB phase microscope connected to a Polaroid CCD camera and an Apple Macintosh computer for capturing &lt;b&gt;images&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-2-18.anc" start="30010" end="30015" sStart="null" offset="0" sid="null" wn="3" wnkey="image%1:06:00::" text="To quantitate the amount of spreading, each &lt;b&gt;image&lt;/b&gt; was analyzed with the NIH &lt;b&gt;Image&lt;/b&gt; 1.61 application to determine the total amount of area covered by cells and this number was divided by the total number of cells in the &lt;b&gt;image&lt;/b&gt; to give an average area per cell (in pixels 2/cell)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-2-18.anc" start="19538" end="19546" sStart="null" offset="191" sid="r11.function.n.0550" wn="3" wnkey="function%1:04:00::" text="Taken together, these results indicate that the first type III repeat of fibronectin can serve as a cell binding domain and that both integrins and cell surface HSPGs function as receptors for this type III repeat." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-2-18.anc" start="17263" end="17267" sStart="null" offset="74" sid="r9.full.j.0261" wn="2" wnkey="full%5:00:01:whole:00" text="RASMC lysates were subjected to partial heparitinase treatment (full digestion was not performed in order to allow some GAGs to remain associated with the core proteins) then applied to either III1-C or III 11-C Sepharose." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-2-18.anc" start="28532" end="28537" sStart="null" offset="0" sid="null" wn="1" wnkey="add%2:30:00::" text="5 mg/ml) was &lt;b&gt;added&lt;/b&gt; to stabilize the antibody for subsequent handling." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-2-18.anc" start="4515" end="4522" sStart="null" offset="242" sid="r11.absence.n.0925" wn="1" wnkey="absence%1:26:00::" text="Cells seeded onto fibronectin coated dishes with III1-C in the culture medium spread more extensively and in a more circular pattern at early times after plating than cells plated on fibronectin in the absence of III1-C (Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-2-18.anc" start="11738" end="11745" sStart="null" offset="63" sid="r11.absence.n.0078" wn="1" wnkey="absence%1:26:00::" text="Plating RASMCs onto a fibronectin coated dish in the absence of growth factors yielded moderate activation of ERK1/2, which peaked at 30 min then decreased somewhat over the next 30 min of the experiment (Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-2-18.anc" start="29221" end="29228" sStart="null" offset="132" sid="r11.absence.n.0921" wn="1" wnkey="absence%1:26:00::" text="Cells were washed 3 times with DMEM + 0.5% BSA, then resuspended at 1 ? 10 5cells/ml in DMEM + 0.5% BSA, in the absence or presence of 25 ?M III1-C or 25 ?M III 11-C in the medium." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-2-18.anc" start="11738" end="11745" sStart="null" offset="63" sid="r11.absence.n.0078" wn="1" wnkey="absence%1:26:00::" text="Plating RASMCs onto a fibronectin coated dish in the absence of growth factors yielded moderate activation of ERK1/2, which peaked at 30 min then decreased somewhat over the next 30 min of the experiment (Fig." />
  </sentences>
</list>